Our Recommendations
- Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV (2022)
- Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV (2020)
- Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men (2018)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management (2018)
New Publications
- Preventing HIV misdiagnosis: implementation guide (2024)
- Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes (2023)
- HIV Testing Approaches to Optimize Prevention and Treatment for Key and Priority Populations in Malawi (2022)
- WFP Malawi Country Brief, April 2022 (2022)
- Dolutegravir Resistance in Malawi’s National HIV Treatment Program (2022)
Filter
346
Featured
Recommendations
13
New Publications
33
Language
Document type
No document type
121
Guidelines
116
Studies & Reports
62
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Online Courses
1
Countries / Regions
Malawi
8
Latin America and the Carribbean
7
South Africa
7
Global
6
Africa
5
East and Southern Africa
5
Uganda
4
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Kenya
2
Lesotho
2
USA
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
HIV & STI
39
Policies & Guidelines HIV & TB
10
TB
8
Guidelines
7
Studies & Reports
7
Reproductive Health
6
COVID-19
4
Gynaecology & Obstetrics
4
Hepatitis
3
Women & Child Health
3
Capacity Building
3
Dermatology
2
Virology
2
Non-communicable Diseases
2
Family Planning
1
x MEDBOX Issue Brief & Annual Reports x
1
Cervical Cancer
1
Chagas
1
Training Manuals
1
Demograhic Health Surveys DHS
1
Community Health
1
Information, Education and Communication (IEC)
1
Statistics
1
Other
1
Surgery & Anaesthesia
1
Nutrition
1
Maternal Health
1
Leishmaniasis
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
56
Clinical Aspects, Treatment & Prevention
49
Antiretroviral Treatment ART
47
Women
39
Clinical Aspects
37
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
ART Drug Resistance
26
Male Circumcision
23
Treatment Guidelines HIV
23
HIV and COVID-19
23
COVID-19
22
Opportunistic Infections
19
Prevention Guidelines
18
HIV service delivery
17
Access to treatment and laboratory
15
Co-Morbidities (except TB)
15
Treatment & Prevention
14
Policies
10
Prophylactic Treatment
10
Adherence
9
Testing Guidelines
8
Global Impact: Socio-economic, health services, TB & HIV
7
General Reports
6
Children & Adolescents
5
Community Worker
5
Eastern and Southern Africa
5
Drug resistance
4
Prevention of mother-to-child transmission (PMTCT)
4
Latin America & the Carribean
4
Prevention & Control
3
Others
3
Immunization Guidelines
3
Health Worker
3
Policies and guidelines
3
Reports & Studies Children HIV
3
HIV in Key Populations
3
Eastern Europe and central Asia
3
Policies & Strategies
2
Global
2
Laboratory
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Country specific documents
2
Gender Aspects
2
TB/HIV
2
Asia and Pacific
2
HIV and coinfection
2
TB/HIV Coinfection
2
Drugs
1
Adults
1
HIV surveillance
1
Substance Use Disorders, Others
1
Inclusion
1
HIV testing & disclosure
1
Transgender People
1
Sexually Transmitted Infections
1
Men who have sex with men (MSM)
1
HIV
1
People who injecting Drugs
1
HIV / AIDS
1
Reports
1
General
1
Clinical Guidelines
1
Online Courses & Resources
1
For Pregnant Women
1
Training, others
1
For Migrants & Refugees
1
Prison & Detention
1
For Older People
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Long-term Care Facilities
1
TB/COVID-19
1
Community Health Workers CHW
1
HIV &TB
1
Information Refugees Ukraine
1
Zoonoses
1
NTDs
1
Chagas
1
Clinical Aspects & Diagnostics
1
Prevention & Strategies
1
Gynaecological Cancers
1
General Aspects
1
Malawi
1
For Community Health Workers
1
Nutrition
1
Research & Access
1
TB
1
Lobby and Advocacy
1
Depression
1
Prisoners
1
Contraceptive Dynamics Following HIV Testing
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
Herramienta de estimación de necesidades y costos de la profilaxis preexposición (PrEP). Instruccciones de uso. En particular, calcula 1) el número de personas que se beneficiarían de la PrEP, en cada población relevante; 2) el total de personas que el país o entidad tiene capacidad para cubri...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at red...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and...
This technical brief aims to support these trends, accelerated by the COVID-19 pandemic, and improve PrEP uptake, persistence, and effective use by providing implementation guidance for differentiated and simplified service delivery. The brief aims to support a range of stakeholders in planning and ...
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is o...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
All countries in the Latin American and Caribbean (LAC) region are expected to report on these indicators for the year 2022.
